Approval · Notice of Compliance 38397 · 2026
ACTIFEMME LD: Notice of Compliance 38397
Issued October 1, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38397
- Date
- October 1, 2026
- Company
- Novast Laboratories Ltd.Nantong, China
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ACTIVELLE LD
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIFEMME LD | 02571749 | Approved |
Medicinal ingredients
- NORETHINDRONE ACETATE 0.1 MG per TAB
- ESTRADIOL HEMIHYDRATE 0.5 MG per TAB